Amogh Sivarapatna, Ph.D. Vice President

Amogh Sivarapatna, Ph.D. is a Vice President at HCR. Dr. Sivarapatna primarily supports HCR’s research efforts. Dr. Sivarapatna also participates in HCR business development activities as well as HCR’s transaction-related activities, including financial analysis, transaction structuring and due diligence.

Prior to joining HCR, Dr. Sivarapatna was a life sciences strategy consultant at L.E.K. Consulting. Dr. Sivarapatna holds a Ph.D. in biomedical engineering from Yale University, where he focused on regenerative medicine and vascular tissue engineering applications of pluripotent stem cells. Prior to that, he received his B.S. in biomedical engineering from University of Virginia.